Clinical Trial Update: Lonafarnib for Chronic Hepatitis D [Phase 2]

View source ↗

Summary

Phase 2 trial of lonafarnib for chronic hepatitis D has completed and results were posted on 2016-08-31.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Lonafarnib (lonafarnib)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis D | Phase 2 | Status: COMPLETED | Results posted: 2016-08-31